Insights
There is always something exciting happening at Lockton. Here are just a few from our newsroom.
2025 Trend outlook shows little healthcare cost relief in sight
Medical and pharmacy trend reached 8.1% in 2024 Medical and pharmacy trends have returned to a more stable level after previous volatility, slowing down to 8.1% compared to 10.2% the year prior. Despite this stabilization, healthcare costs are expec …
GLP-1 Indications continue to expand: Potential approvals expected through 2026
Following other expanded indications for GLP-1s, Wegovy has now received FDA approval for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate-to-advanced fibrosis. This marks a significant expansion in the …
New Lockton webcast series addresses the latest changes to leave law compliance
With 2026 quickly approaching, employers face an increasingly complex patchwork of new and amended state leave laws. To address these compliance challenges, Lockton is introducing its Fall 2025 Paid Leave Webcast Series, presented by our Integrated A …
For emerging digital asset treasury companies, risk and insurance strategy is key
As digital assets become mainstream, companies across industries are making cryptocurrencies a core part of their financial strategies. While the growth potential is significant, this shift brings unique operational, regulatory, and security risks th …
Planning for and responding to workplace violence threats
The recent deaths of four people in a Midtown Manhattan office building shooting are an unfortunate reminder of the persistent threat workplace violence represents for both employers and employees. Such events can have broad impacts, including potent …
Cybersecurity at sea: What the Coast Guard’s new rule means for U.S. vessel operators
The U.S. Coast Guard has rolled out a major cybersecurity regulation that’s set to change how maritime companies think about digital risk, requiring them to report cyber incidents and build cybersecurity governance frameworks. This isn’t just another …
